The objective of this Administrative Core (Core A) is to support the mission of the University of Pennsylvania (Penn) Alzheimer's Disease (AD) Core Center (ADCC) by facilitating efforts to increase research and understanding of AD and related disorders as well as mild cognitive impairment (MCI) and healthy aging at and beyond Penn. Core A also sets the direction ofthe ADCC, guides development of its programs, promotes interactions of its investigators with National Institute on Aging (NIA) funded AD Centers (ADCs), the National AD Coordinating Center (NACC), the AD Cooperative Study (ADCS), the AD Education and Referral (ADEAR) Center, the AD Neuroimaging Initiative (ADNI), the AD Genetics Consortium (ADGC) and other related NIH and public/private agency supported initiatives focused on AD and related disorders. Core A will accomplish these goals through five highly effective mechanisms. First, Core A provides fiscal and administrative oversight of the ADCC, and the ADCC Executive Committee meets regularly to review ADCC activities and address issues as they arise. Second, Pilot grant applications are solicited annually, and the ADCC Pilot Review Committee identifies 2 meritorious Pilots for funding each year by the ADCC as well as 1-3 additional Pilots funded by the Penn Institute on Aging (lOA) which partners with the ADCC in this Pilot program. Third, Core A organizes annual reviews ofthe Penn ADCC by the ADCC External Advisory Committee. Fourth, Core A facilitates participation of ADCC investigators in annual Penn-wide retreats held by the lOA and the Center for Neurodegenerative Disease Research (CNDR) for students, postdoctoral fellows and faculty from a wide range of disciplines in neuroscience and aging. Finally, Core A promotes interactions of the Penn ADCC with NACC, ADCS, ADEAR, ADNI, ADGC and other ADCs in education and research initiatives. Thus, Core A provides a clearly delineated administrative structure that enables the Penn ADCC to increase the quality and quantity of clinical and basic research as well as educational activities on AD and related disorders as well as MCI and normal aging at and beyond Penn.

Public Health Relevance

;Administrative Core A is highly relevant to the continued success of the Penn ADCC because it exercises fiscal and administrative oversight over this Center, facilitates interactions among ADCC investigators to accomplish the research conducted in programs linked to the Penn ADCC which is the foundational neurodegenerative disease program that has spawned/enabled other neurodegenerative disease research programs at Penn. Finally, Core A coordinates and integrates activities ofthe Cores, and provides mechanisms to advise the Principal Investigator and Core Leaders of this PPG on their progress towards accomplishing the goals of NIA funded ADCCs.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1-ZIJ-5)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
United States
Zip Code
LoBue, Christian; Wadsworth, Hannah; Wilmoth, Kristin et al. (2017) Traumatic brain injury history is associated with earlier age of onset of Alzheimer disease. Clin Neuropsychol 31:85-98
Cousins, Katheryn A Q; Ash, Sharon; Irwin, David J et al. (2017) Dissociable substrates underlie the production of abstract and concrete nouns. Brain Lang 165:45-54
Henderson, Michael X; Chung, Charlotte Hiu-Yan; Riddle, Dawn M et al. (2017) Unbiased Proteomics of Early Lewy Body Formation Model Implicates Active Microtubule Affinity-Regulating Kinases (MARKs) in Synucleinopathies. J Neurosci 37:5870-5884
Bell, S P; Liu, D; Samuels, L R et al. (2017) Late-Life Body Mass Index, Rapid Weight Loss, Apolipoprotein E ?4 and the Risk of Cognitive Decline and Incident Dementia. J Nutr Health Aging 21:1259-1267
Phillips, Jeffrey S; Da Re, Fulvio; Dratch, Laynie et al. (2017) Neocortical origin and progression of gray matter atrophy in nonamnestic Alzheimer's disease. Neurobiol Aging 63:75-87
Brown, Christopher A; Johnson, Nathan F; Anderson-Mooney, Amelia J et al. (2017) Development, validation and application of a new fornix template for studies of aging and preclinical Alzheimer's disease. Neuroimage Clin 13:106-115
Chapuis, Julien; Flaig, Amandine; Grenier-Boley, Benjamin et al. (2017) Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism. Acta Neuropathol 133:955-966
Lee, Edward B; Porta, Sílvia; Michael Baer, G et al. (2017) Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol 134:65-78
Monsell, Sarah E; Mock, Charles; Fardo, David W et al. (2017) Genetic Comparison of Symptomatic and Asymptomatic Persons With Alzheimer Disease Neuropathology. Alzheimer Dis Assoc Disord 31:232-238
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384

Showing the most recent 10 out of 586 publications